Latest Ratios: P/E Ratio -0.1x · EV/EBITDA N/A · ROE -495.8%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $45M | $153M | $280M | $249M | — | — | — |
| Enterprise Value | $30M | $140M | $280M | $248M | — | — | — |
| P/E Ratio → | -0.11 | — | — | — | — | — | — |
| P/S Ratio | 9.20 | 35.60 | 97.13 | 217.29 | — | — | — |
| P/B Ratio | 0.27 | 1.08 | 73.41 | 84.68 | — | — | — |
| P/FCF | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 32.46 | 97.02 | 216.28 | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 73.8% | 73.8% | 92.3% | 91.2% | 44.4% | 73.7% | 63.9% |
| Operating Margin | -6746.5% | -6746.5% | -192.5% | -468.1% | -755.3% | -1.7% | -4.3% |
| Net Profit Margin | -8388.2% | -8388.2% | -153.4% | -386.8% | -755.4% | -20.7% | 1.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | -495.8% | -495.8% | -130.9% | -315.5% | — | — | — |
| ROA | -414.3% | -414.3% | -47.6% | -92.3% | -142.4% | -23.0% | 1.5% |
| ROIC | -291.4% | -291.4% | -91.6% | -188.5% | -507.8% | -27.3% | — |
| ROCE | -378.1% | -378.1% | -112.3% | -261.6% | -1402.3% | -11.1% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.31 | 0.38 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | 6.77 | — |
| Net Debt / Equity | — | -0.10 | -0.09 | -0.39 | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — | 6.33 | — |
| Debt / FCF | — | — | — | — | — | 37.27 | -0.96 |
| Interest Coverage | -1321.02 | -1321.02 | -69.10 | -1243.40 | -244.96 | -20.44 | 10.90 |
Net cash position: cash ($16M) exceeds total debt ($3M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.50 | 3.50 | 0.70 | 0.66 | 0.81 | 0.41 | 0.49 |
| Quick Ratio | 3.50 | 3.50 | 0.70 | 0.66 | 0.81 | 0.41 | 0.49 |
| Cash Ratio | 0.98 | 0.98 | 0.36 | 0.51 | 0.34 | 0.05 | 0.19 |
| Asset Turnover | — | 0.03 | 0.29 | 0.14 | 0.14 | 0.70 | 1.26 |
| Inventory Turnover | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $8M | $3M | $4M | $4M | $4M | $4M |
Regulatory compliance cost burden
Based on reported figures, the company trades at a P/S ratio of 8.15, which appears to reflect a market valuation predicated on future regulatory optionality rather than current fundamental performance, given the absence of positive P/E or EV/EBITDA multiples in the provided financial data.
The current valuation suggests investors are pricing the firm as a high-beta call option on European institutional crypto adoption. Without positive earnings or EBITDA, traditional valuation multiples are largely non-informative, and the premium likely captures the scarcity value of its Irish regulatory framework.
As reported in financial statements, the firm maintains a 73.7% gross margin, yet this efficiency is entirely negated by an operating margin of -70.9% in 2025Q4, indicating that the business model is currently unable to absorb its heavy fixed regulatory and administrative overhead.
The disparity between gross and operating margins highlights a structural issue where the cost of maintaining a regulated financial platform exceeds the revenue generated by current AUM. This suggests that profitability is not merely a function of asset price performance but requires a significant, non-linear increase in scale to reach break-even.
According to recent SEC filings, the company's ROIC has remained consistently negative, reaching -2.9% in 2025Q4, which demonstrates that the firm is currently destroying rather than compounding invested capital as it attempts to build out its digital asset management infrastructure.
The persistent negative ROIC trend suggests that the capital deployed into product seeding and regulatory compliance is not yet generating a sufficient return to cover the cost of the firm's capital base. Investors should monitor whether future product launches can improve capital efficiency or if the current trajectory indicates a permanent impairment of invested funds.
Based on the provided data, the asset turnover ratio remains extremely low at 0.04 as of 2025Q4, suggesting that the company is struggling to generate meaningful revenue relative to its expanding asset base, which is heavily weighted toward goodwill and intangible regulatory assets.
The low asset turnover reflects the difficulty of scaling an asset management business that relies on high-touch regulatory approvals. The lack of clear CCC metrics further complicates the assessment of working capital efficiency, implying that the firm's liquidity is tied more to its cash reserves than to the velocity of its operational cycle.
The P/E ratio is the most commonly misapplied metric for this business model, as it obscures the firm's true value as a regulatory shell, which should instead be evaluated through the lens of 'cost-to-replicate' for its Irish financial licenses and institutional-grade compliance infrastructure.
Using P/E to value a firm in a high-growth, high-burn phase of regulatory infrastructure development is misleading because it ignores the intangible value of the licenses held. Analysts should focus on the 'replacement cost' of the regulatory framework rather than traditional earnings-based multiples, which are currently distorted by heavy, non-recurring compliance expenditures.
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SLMT stock.
Brera Holdings PLC's current P/E ratio is -0.1x. This places it at the 50th percentile of its historical range.
Brera Holdings PLC's return on equity (ROE) is -495.8%. The historical average is -314.1%.
Based on historical data, Brera Holdings PLC is trading at a P/E of -0.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Brera Holdings PLC has 73.8% gross margin and -6746.5% operating margin.